Human epidermis is continuously exposed to environmental mutagenic hazard and is the most frequent target of human cancer. How the epidermis coordinates proliferation with differentiation to maintain homeostasis, even in hyperproliferative conditions, is unclear. For instance, overactivation of the proto-oncogene MYC in keratinocytes stimulates differentiation. Here we explore the cell cycle regulation as proliferating human keratinocytes commit to terminal differentiation upon loss of anchorage or overactivation of MYC. The S-phase of the cell cycle is deregulated as mitotic regulators are inhibited in the onset of differentiation. Experimental inhibition of mitotic kinase cdk1 or kinases of the mitosis spindle checkpoint Aurora B or Pololike Kinase, triggered keratinocyte terminal differentiation. Furthermore, hyperactivation of the cell cycle by overexpressing the DNA replication regulator Cyclin E induced mitosis failure and differentiation. Inhibition of Cyclin E by shRNAs attenuated the induction of differentiation by MYC. In addition, we present evidence that Cyclin E induces DNA damage and the p53 pathway. The results provide novel clues for the mechanisms committing proliferative keratinocytes to differentiate, with implications for tissue homeostasis maintenance, HPV amplification and tumorigenesis.
INTRODUCTION
Epidermal homeostasis involves continuous cell renewal, expansion and enlargement. 1, 2 In the basal layer of the epidermis, mainly quiescent, reside the epidermal stem cells. Some daughters of the stem cells activate their cell cycle, undergo a short clonal expansion phase of rapid proliferation and migrate into the suprabasal layers. As they leave the basal layer, they cease proliferation, initiate terminal differentiation and increase their cellular size. 3, 4 The mechanisms that coordinate epidermal keratinocyte cell growth and differentiation are unclear. Actively proliferating cells have a limited potential, as they are committed to differentiate after four or five rounds of cell divisions by unknown mechanisms. 1 Epidermal proliferation and differentiation are controlled by cell adhesion to the basement membrane via integrins. Terminal differentiation can be rapidly induced by depriving keratinocytes of cell anchorage in suspended cultures. 5 Proto-oncogene MYC, a potent inducer of cell growth and cell cycle, 6 stimulates epidermal stem cell differentiation. 7, 8 Activation of ectopic MYC in basal cells favours differentiation versus proliferation, what causes a rise of differentiation markers after 4 --5 days. We previously proposed that this is the time required by keratinocyte to undergo the clonal expansion phase of rapid proliferation that precedes terminal differentiation. 7 MYC drives differentiation in part by inhibiting cell adhesion. 7, 8 However, the cell cycle mechanisms by which MYC elicits this function have not been elucidated.
We have previously shown that postmitotic keratinocytes continue DNA synthesis and become polyploid during differentiation in vitro 9 and in vivo, 10, 11 and that the process of endoreplication is stimulated by MYC. As for MYC, other molecules involved in cell cycle progression caused epidermal hyperplasia, but were not able to disrupt differentiation (for example, E2F, Cyclin D1, MDM2, cdk2, cdk4; references in Zanet et al. 11 ). Cyclin-dependent kinases cdk2 and cdk1 are key regulators of S-phase and mitosis, respectively. 12 In order to gain insight into the mechanisms linking cell growth with differentiation, we have compared the dynamics of Cyclin/cdk complexes during the commitment to differentiation in normal keratinocytes or after MYC overactivation. We have inhibited cell cycle kinases, including kinases of the mitosis spindle checkpoint, and explored the effects on differentiation. The results reveal that the cell cycle is deregulated in the onset of differentiation, involving strong accumulation of the S-phase regulator Cyclin E. Overexpression of Cyclin E in human basal keratinocytes induced a mitosis block, re-replication and differentiation. This response appears to be part of a novel keratinocyte anti-proliferative mitosis-differentiation checkpoint. Interestingly, MYC might promote keratinocyte differentiation by inducing Cyclin E. In turn, accumulation of Cyclin E would trigger the mitosis checkpoints by causing DNA damage and inducing the p53/p21 pathway. This mechanism might explain how actively proliferating keratinocytes commit to differentiation and how the epidermis is protected from cell growth alterations.
RESULTS

Cdk complexes of S-phase and mitosis during suspension-induced differentiation
Integrins mediate cell adhesion to the basal membrane of the epidermis and sustain keratinocyte proliferation. 13 Inactivation of integrin function in suspension rapidly triggers terminal differentiation. Within 5 h keratinocytes irreversibly lose their capacity to proliferate and commit to differentiate. 5 By 24 h all cells are differentiated. We placed primary keratinocytes in suspension to analyse changes in the cell cycle during the transition to differentiation. Epidermal differentiation is associated with morphological changes and with the induction of the cornified precursor involucrin that can be assessed by flow cytometry (Figure 1a and Supplementary Figure 1a) . 9, 14 Cellular size and complexity (light scattering), and the expression of involucrin increased markedly after 12 h in suspension.
Bromodeoxyuridine (5-bromo-2 0 -deoxyuridine, BrdU) incorporation experiments showed that DNA synthesis stays active during differentiation ( Figure 1a and Supplementary Figure 1a) . Labellingadherent cycling cells by a BrdU pulse before suspension showed that differentiating cells accumulated in G2/M by 12 h and subsequently, bypassed mitosis and became polyploid (Supplementary Figure 1a) . Therefore, DNA synthesis stayed active during differentiation beyond the time of commitment (6 h). Concomitantly, we analysed the dynamics of cdk2 and cdk1 complexes. Cyclin E/cdk2 complexes control DNA replication, Cyclin A binds to cdk2 or to cdk1 during the S/G2 transition, and Cyclin B/cdk1 controls mitosis. 12 The Cyclin A/cdk2 complex has been previously shown to depend on cell anchorage, 15 also in keratinocytes. 16, 17 Expression of Cyclins A and B was high for the first 6 h in suspension but it was suppressed by 12 h (Figures 1b and 2a and Supplementary Figure 1b) . Strikingly, Cyclin E followed an opposite pattern, and markedly accumulated from 6 to 24 h (Figures 1b and 2a and Supplementary Figure 1b) . Similar results were observed by confocal microscopy analyses of stratified cultures ( Figure 1c and Supplementary Figure 2) . Interestingly, the switch from mitotic Cyclins to high Cyclin E was associated with the increase in cell size and involucrin expression, characteristics of epidermal differentiation (Figures 1a-c and 2a and Supplementary Figures 1-3) . 3, 4 Consistent with the changes in Cyclin expression, the expression of mitotic kinase cdk1 was downregulated in suspended cells (Figure 1b) . Although the expression of Cyclin E and cdk2 proteins was sustained, all the kinase activities were inhibited after 6 h in suspension (Figure 1d ). The inhibition of Cyclin A-associated activity preceded the inhibition of Cyclin B-associated activity, which was still high by 6 h. Both became undetectable by 12 h. However, a remaining low Cyclin E-associated activity was detectable by 12 h. Cyclin B and Cyclin E activities increased slightly and tumour suppressor Rb and histone H3 were hyperphosphorylated as soon as cells were placed in suspension by trypsin treatment (0 h: Figures 1b and 2a) . Inactivation of Rb by phosphorylation marks cell cycle entry and total Rb is downregulated during keratinocyte differentiation. 16, 18 Consistent with previous reports, 16, 17 cdk inhibitors p21CIP1 (hereafter, p21) and p27KIP1 (hereafter, p27) were upregulated in suspension (Figure 1b) . However, whereas p27 reached maximum levels late during differentiation, p21 was transiently induced by the time of commitment (6 h).
We next analysed the dynamics of Cyclin/cdk complexes by immunoprecipitation (IP) and western blotting (WB; Figure 1e and Supplementary Figure 4a) . Cyclin A bound to both cdk2 and cdk1 (Figure 1e) . By 12 h, the detection of both kinases in Cyclin A IPs was much reduced and by 24 h, only the inactive form of cdk1 was barely detectable (Figure 1e ). Cyclin B/cdk1 peaked by 6 h. Increasing levels of cdk2 were detected in Cyclin E IPs up to 24 h (Figure 1e ; PSTAIR is a homologous motive of the cdks; Cyclin E binds to cdk2). It is worth noting that the binding of the cdk inhibitor p21 to Cyclin B complexes peaked by 6 h whereas the binding of p21 to Cyclin E complexes peaked by 12 h (Figure 1e) . Reverse experiments by pulling down p21 showed consistent results ( Figure 1e) . p21 was barely detectable in Cyclin E IPs after 24 h, suggesting that most of the Cyclin E protein was free of the inhibitor (Figure 1e ). Conversely, IP for p21 revealed a neat band of Cyclin E by 24 h, suggesting that most of the p21 protein was bound to Cyclin E/cdk2 (Figure 1e ). In summary, the transient increase of p21 appears to suffice to inhibit the mitotic Cyclin/cdk complexes by 6 h, but not the high levels of Cyclin E that are subsequently produced. Consistently, immunodepletion of p21 in cell lysates removed most of the Cyclin A/cdk complex by 6 h, but left significant levels of Cyclin E/cdk2 complex by 12 h (Supplementary Figure 4a) . Interestingly, downregulation of Cyclin A in suspended mouse keratinocytes requires p21. 17 Cdk complexes of S-phase and mitosis during MYC-induced differentiation Constitutive activation of proto-oncogene MYC drives epidermal stem cells into the clonal amplification phase (referred to as transit amplifying cells or TAC) that precedes terminal differentiation. 7, 8 Once terminal differentiation initiates, MYC is downregulated (Figure 2a) . 19, 20 Keratinocytes expressing MYCER constitute an inducible differentiation system in the presence of cell adhesion that is more gradual than the suspension method. An increase in the proportion of terminally differentiating cells is observed over 5 days after the activation of MYCER, the time estimated for stem cells to amplify before differentiation (see involucrin in Figure 2a ). 7, 9 We have examined the dynamics of cdk complexes during MYC-promoted differentiation. As the induction of differentiation by MYC is more gradual than in the suspension system, the changes were not as marked but were consistent. A transient increase of the expression of Cyclins A and B was observed over 2 --3 days after MYCER activation (Figure 2a and Supplementary Figure 4c) . In contrast, MYC continuously induced the expression of Cyclin E (Figure 2a ). This is consistent with previous reports showing that MYC induces Cyclin E expression. 21, 22 The kinase activities associated with Cyclin A, Cyclin B and cdk2 increased over the first 2 days and dropped by 7 days below the initial levels ( Figure 2b) . Cyclin E-associated activity also increased and decreased to levels similar to the start of the experiment ( Figure 2b ). All regulators thus reflected an early activation of the cell cycle by MYC. Consistently, the hyperphosphorylated (inactive) form of Rb became predominant by 6 --12 h and phospho-Rb Ser780 and phospho-cdk2 Y15 increased after MYCER activation (bars, Figure 2c and Supplementary Figure 4b ). The inhibition of the kinase activities after 3 days might be due to the striking transient induction of total p21 levels ( Figure 2c ). p21 bound to both Cyclin A and Cyclin E complexes in the presence of activated MYC (Supplementary Figure 4c) . In contrast, p27 was undetectable in the MYCER keratinocytes ( Figure 2c) .
Altogether, the results suggest that the transient induction of p21 might be a keratinocyte response to cell cycle deregulation. Expression of p21 has been previously described in the epidermis. 23 To further study this issue, we isolated keratinocytes from the normal human skin and selected stem cells, transit amplifying cells and terminally differentiating cells on the basis of their adhesion capacity via integrins.
14 Strong expression of p21 was detected in the slowly adhering population, previously defined as transit amplifying cells (TAC; Figure 2d ). The presence of p21 was again accompanied by a higher phosphorylation of Rb ( Figure 2d ). These results were therefore consistent in suspensioninduced differentiation, MYC-induced differentiation and spontaneously occurring differentiation.
Mitosis block and differentiation
The results reported above suggest that keratinocyte differentiation involves mitotic inhibition and cell cycle deregulation. To functionally explore this issue, we treated normal primary keratinocytes with cdk inhibitors in order to block either DNA replication cdk2 or mitosis cdk1. The specificity of these inhibitors on cdk2 or cdk1 vary depending on the concentration and the cell type. 24 However, AG555 was identified as a cdk2 inhibitor. 25, 26 Roscovitine and NG97 were selected by searching for inhibitors of Cyclin B/cdk1 and have been shown to block the mitosis machinery. 27 --29 As it is not technically possible to test the activity of the inhibitors in vivo, we tested their capacity to inhibit S-phase or mitosis by analysing their effect on DNA replication and cell cycle. 30, 31 Treating primary keratinocytes with AG555 for 48 h at the concentration used in Figure 3a significantly inhibited progression through S-phase, causing an accumulation of cells in G1/S and a reduced G2/M phase. In contrast, although Roscovitine and NG97 have the capacity to inhibit both cdk1 and cdk2, they provoked a marked accumulation of keratinocytes in G2/M and polyploidy and yet allowed DNA replication ( Figure 3a To further determine whether inhibition of cdk1 triggered terminal differentiation, we expressed specific short hairpin RNAs (shRNAs) in primary keratinocytes by lentiviral infection. Two different shRNAs were able to inhibit the expression of endogenous cdk1 as analysed by real-time reverse transcription --polymerase chain reaction (RT --PCR; Figure 3b ). The cell cultures showed areas of rounded cells typical of mitosis arrest (Supplementary Figure 7) . Inhibition of cdk1 provoked an increase in the proportion of cells expressing the terminal differentiation keratins K1 and K10 as measured either by RT --PCR or by percentage of positive cells (Figure 3b) .
Genotoxic agents might cause keratinocyte differentiation by triggering a mitosis checkpoint. 11 Mitosis kinases Aurora B or Polo-like kinase 1 (Plk1), which are involved in chromosome segregation, participate in the mitotic spindle checkpoint 32, 33 and some of their inhibitors are being tested in cancer clinical trials. 34 To explore whether the keratinocyte mitotic checkpoints are involved in the signal to differentiation, we inhibited these molecules by specific chemical inhibitors. A 48 h treatment with Aurora B kinase inhibitor, ZM447439 35 or Plk1 inhibitor, BI2536 36 strongly induced an accumulation of keratinocytes in G2/ M and polyploidy and a remarkable increase of cell size and differentiation ( Figure 4a and Supplementary Figures 5 and 6 ).
To confirm the specificity of the effects, we inhibited Aurora B in keratinocytes by transfection of specific small interference RNA (siRNA). Transient inhibition of Aurora B produced 24 h after transfection a significant increase in the proportion of cells expressing the differentiation marker involucrin (Figure 4b ).
The induction of terminal differentiation by the mitotic inhibitors was irreversible as cells did not recover colony growth after being released from the 48 h treatment with Roscovitine or BI2536 (Figure 4c and Supplementary Figure 6 ). In contrast, the colonies grew bigger after the G1/S block by the AG555 inhibitor ( Figure 4c and Supplementary Figure 6 ).
Overexpression of Cyclin E-GFP
We have shown that epidermal differentiation is associated with a marked accumulation of Cyclin E in vitro (Figures 1a and 2a and Supplementary Figures 5 and 6 ) and in vivo.
11 To test whether a direct hyperactivation of the cell cycle is able to drive differentiation, we constructed a retroviral green fluorescent protein (GFP) form of Cyclin E under a constitutive retroviral promoter for its expression in basal primary keratinocytes (Figures 5a and b and Supplementary Figure 8a) . In vitro assays showed that Cyclin E-GFP was functional in activating cdk2 (Supplementary Figure 8b and not shown). The exogenous Cyclin E-GFP localised to the nucleus and was sensitive to posttranscriptional regulation, as it was absent in metaphasic cells (Supplementary Figure 9a, INSET) , as described for the wild-type protein.
12 Keratinocytes overexpressing Cyclin E-GFP (KCEGFP) were significantly larger and presented large or various nuclei (Figure 5b and Supplementary Figure 9a) . KCEGFP cultures widely expressed the terminal differentiation marker involucrin (Figure 5b) .
Flow-cytometry analyses of unselected cultures after infection with Cyclin E-GFP (GFP þ /À; Figure 5c Figure 9c) , and a decrease in Cyclin A, consistent with terminal differentiation (Figure 5d ; see Figure 1a ).
Overexpression of Cyclin E caused a reduction in the clonogenic amplification capacity (Figure 6a ). This reduction was not due to senescence (Supplementary Figure 10) or apoptosis (no sub-G1 in the DNA content profiles; Figure 5c and Supplementary Figure 9b) . Basal KCEGFP were able to attach and to proliferate but formed a higher proportion of abortive-differentiated colonies (Figure 6a ). The increased terminal differentiation rate was further confirmed by a higher expression of keratins K1 and 10 ( Figure 6b and Supplementary Figure 9d) and by assays on the capacity to form cornified envelops, the final product of epidermal differentiation (Figure 6c) . 37 Therefore, all the parameters analysed show that the activation of the cell cycle by Cyclin E in basal keratinocytes results in terminal differentiation.
MYC has been shown to induce Cyclin E. 21, 22 Activation of conditional MYCER significantly induced Cyclin E in keratinocytes (Figures 2a and 6d) . We questioned whether Cyclin E might Cyclin E and DNA damage We have shown that triggering the spindle mitosis checkpoint causes in keratinocytes mitotic failure and differentiation ( Figure 4 and Supplementary Figures 5 and 6 ). This effect is also provoked by genotoxic agents such as bleomycin or a topoisomerase II inhibitor. 11 We investigated whether overexpression of Cyclin E caused DNA damage by measuring the phosphorylation of histone H2ax (P-gH2ax), an early marker of DNA repair. 38 As summarised in Figures 7a and b , KCEGFP strikingly accumulated DNA damage as compared with control keratinocytes overexpressing GFP only. Interestingly, ectopic Cyclin E induced the expression of the p53/p21 pathway (Figure 7c ). The p53 pathway is induced in response to DNA damage and triggers mitotic checkpoints. 39 We next tested whether an accumulation of DNA damage might trigger the mitosis block and terminal differentiation effects observed in KCEGFP cells. To this aim, we treated keratinocytes with doxorubicin (DOXO), a known DNA-damaging agent. 40 DOXO treatment strongly induced DNA damage by 24 h (P-gH2ax; Figure 8a ), the p53/p21 pathway ( Figure 8b ) and a mitosis arrest (Figure 8c) . As a result, keratinocytes were rapidly induced to undergo terminal differentiation (Figure 8c) , resembling the effects observed after a direct mitosis block (Figures 3a and 4a) . Interestingly, inhibition of the mitotic checkpoint component Aurora B kinase by ZM447439 did not induce p53 as significantly (ZM; Figure 8b) , consistent with the model that p53 acts upstream of the mitosis block (Figure 8d ).
DISCUSSION
The cell cycle deregulates prior to differentiation It is unclear how keratinocytes coordinate cell multiplication with postmitotic differentiation. Integrins maintain both cell adhesion to the basement membrane and keratinocyte proliferation. 1 We here have shown that primary keratinocytes continue DNA synthesis after loss of anchorage, as they commit to terminal differentiation. 9 While differentiation progressed, keratinocytes accumulated in G2/M and became polyploid. Consistently, we have found that keratinocytes continue DNA replication in the differentiating layers of the human epidermis. 11 Although the activities of cell cycle kinases cdk2 (S phase) and cdk1 (mitosis) were both inhibited in suspended keratinocytes, a remaining low-intensity Cyclin E-associated activity persisted during differentiation. The decrease of the kinase activities in suspended keratinocytes was likely elicited by cell cycle inhibitors such as p21 or p27. Induction of p21 during keratinocyte differentiation has been reported previously. 16, 17, 23, 41 In our experiments, p21 was transiently induced in suspended keratinocytes and bound Cyclin A/cdk1 and Cyclin B/cdk1 at the time of the commitment to differentiation (6 h), whereas the binding to cdk2 peaked later on. Interestingly, p21 is required for the downregulation of Cyclin A in mouse keratinocytes. 17 Although p21 inhibits cdk2 complexes, it is able to bind and inactivate the mitosis complex Cyclin B/cdk1 and yet allow DNA replication. 39, 42, 43 The induction of p21 in suspended keratinocytes might not be sufficient to completely inhibit the large amounts of Cyclin E/cdk2 produced, but it might be sufficient to inhibit the decreased amounts of Cyclin A and Cyclin B. Consistently, the levels of cdk2 required to drive DNA replication appear to be lower than the levels of cdk1 required to trigger mitosis. 44, 45 The low activity of Cyclin E/cdk2 might thus sustain keratinocyte DNA re-replication once differentiation has initiated. Within the same lines, cdk inhibitors Roscovitine and NG97 blocked mitosis and yet allowed DNA replication.
Overactivation of MYC in keratinocytes induced cell cycle changes consistent with the suspension system. The changes were more marked in suspension-induced differentiation, as it is a rapid process that includes complete lack of cell adhesion. In contrast, ectopic activation of MYC is thought to drive keratinocytes into the clonal amplification phase of rapid proliferation that precedes terminal differentiation. 7, 8 Activation of MYCER in keratinocytes for 2 days caused hyperphosphorylation of Rb and a transient induction of the Cyclins, all changes that mark cell cycle entry. Subsequently, ectopic MYC induced p21 and downregulation of mitotic Cyclins A and B. These changes are intriguing, as MYC has been reported to inhibit p21 expression and to induce Cyclin B. 46 --48 However, our results are consistent with the model that MYC function depends on the cell type and the cell context. 10, 49, 50 Interestingly, induction of p21 has also been found in MYCERinduced senescence in the absence of cdk2. 51 The upregulation of p21 in keratinocytes was concomitant with the cell cycle activation by MYC and it was also found in the rapid proliferative population isolated from human basal epidermis.
Activation of MYC in keratinocytes induced expression of Cyclin E, consistent with previous reports in other cell types. 21, 22 The regulation of Cyclins during suspension-induced keratinocyte differentiation is consistent with what we have observed in suprabasal epidermis 11 and with the modified cycle that occurs in endoreplication. 52 --54 Some of these changes have also been observed in keratinocytes harbouring HPV molecules. 55 Postmitotic DNA replication allows a large increase in cell size in endoreplicating systems, including plant epidermis (for example, Zanet et al., 10 Schellmann and Hulskamp 54 and references therein). The switch from proliferative Cyclins to high Cyclin E observed in our experiments correlated with the induction of the differentiation marker involucrin and might explain the cell size increase of differentiating keratinocytes. 3, 4 This in turn reconciles the function of MYC in promoting epidermal differentiation with its well-established function in driving cellular growth.
All the cell cycle regulators analysed increased early after loss of anchorage or MYC activation as keratinocytes committed to differentiation. This included Cyclin/cdk activities and phosphorylation of Rb. In addition, we and others have shown that p53 antagonist MDM2 is upregulated during keratinocyte differentia- tion (Dazard et al. 41 and references therein). Altogether, the results show that there is a loss of inhibition in the S-phase of the cell cycle as keratinocytes commit to differentiation and block mitosis (Figure 8d ). This response to lack of anchorage might account for the loss of proliferative potential as keratinocytes lose adherence to the basal membrane via integrins.
5
A mitosis-differentiation checkpoint The inhibition of mitosis after loss of cell anchorage or MYC activation in keratinocytes might be a response to counterbalance cell cycle hyperactivation. In our experiments, a block of mitosis by inhibiting cdk1 or components of the spindle checkpoint Aurora B kinase or Polo-like kinase, or by causing genotoxic insult by doxorubicin (herein), Bleomycin or topoisomerase II inhibitor ICRF-193, 11 triggered a rapid increase of the keratinocyte cell size and differentiation. This striking rapid response was not observed when keratinocytes were treated with inhibitors of G1/S, AG555 (herein) or hydroxyurea. 9 In contrast, the clonogenic potential of keratinocytes augmented once they were released from a G1 arrest, induced by the cdk inhibitor AG555. This inhibitor slightly reduced cell size and involucrin expression. Along the same lines, overexpression of p21 in keratinocytes slowed down the cell cycle and inhibited differentiation. 16, 23 Consistently, inhibition of Cyclin E by shRNAs, in our experiments, attenuated the differentiation effect caused by MYC. The results altogether suggest that acceleration of the cell cycle supports and promotes keratinocyte differentiation (Figure 8d) . The model is consistent with the notion that epidermal stem cells are mainly quiescent, and that their activation already initiates the differentiation programme. The model is in turn consistent with the fact that MYC promotes keratinocyte differentiation. An uninhibited cell cycle might be a part of the rapid proliferation phase that precedes keratinocyte terminal differentiation. As a response, a keratinocyte mitosis checkpoint might trigger differentiation. This checkpoint might contribute to maintain homeostasis and be part of a tissue self-defence mechanism in the case of genotoxic stress or oncogenic activations, similar to the role that apoptosis or senescence has in other systems. 56, 57 These processes have been found to share some mechanisms. 58 However, MYC has pleiotropic effects in cell metabolism and growth. 6 To challenge the model and to test whether a direct activation of the cell cycle would trigger a differentiation response, we overexpressed Cyclin E in basal keratinocytes.
Cyclin E makes the link Cyclin E accumulates during keratinocyte differentiation both in vitro (herein) and in human epidermis. 11 Overexpression of Cyclin E-GFP induced terminal differentiation of proliferative keratinocytes although the exogenous fusion protein was degraded at mitosis as the natural protein. 12 Despite the increase in DNA replication index upon ectopic Cyclin E, the clonogenic capacity diminished and cells accumulated in G2/M and polyploidy owing to mitosis failure. The loss of proliferative capacity caused by ectopic Cyclin E overexpression was not associated with senescence or apoptosis (see also Gandarillas 58 ) and it was more marked than the inhibition caused by overactivation of MYC. 7 Interestingly, sustained Cyclin E expression resulted in accumulation of DNA damage and induction of p53/ p21, a pathway known to halt the cell cycle in G2/M in response to DNA damage (Figure 8d) . 39 Interestingly, p53 also increased after activation of MYCER in keratinocytes and in the rapid-proliferative fraction of basal human epidermis. 41 Cyclin E is involved in the activation of DNA replication origins and it must be downregulated for cells to undergo cell cycle arrest. 12 Premature Cyclin E expression accelerates cell cycle entry. In addition, oncogenes might promote genomic instability by causing DNA damage. 57 Recent reports have also concluded that acceleration of the cell cycle by Cyclin E can cause DNA damage. 59, 60 Interestingly, in our experiments, causing DNA damage in keratinocytes with genotoxic agents such as doxorubicin induced p53 and terminal differentiation. As discussed above, we have shown that a direct block of mitosis rapidly results in terminal differentiation. By causing DNA damage, accumulation of Cyclin E might trigger the keratinocyte mitosis checkpoints and in turn, terminal differentiation (Figure 8d ). This would create a link between rapid cell amplification and the commitment to terminal differentiation, thus constituting an automatic compensatory mechanism to maintain homeostasis. This model would contribute to explaining how the epidermis maintains tissue structure in benign hyperproliferative situations. Additional alterations breaking the mitosis block response might be required to promote carcinogenesis.
The differentiation effect induced by deregulated Cyclin E does not only have implications for the mechanisms protecting the epidermis against hyperproliferative alterations. For long, a cellautonomous clock-like mechanism has been proposed as one of the possible models determining stem cell fate. The levels of Cyclin E drive cell fate in Drosophila oogenesis. 53 A crossroad between mitosis, differentiation and DNA endoreplication is important in a variety of cell systems, including the plant epidermis or human megakaryocytes. 52 --54 In myeloid leukaemia cells, Cyclin E drives endoreplication 61 and Myc and p21 cooperate to induce megakaryocityc differentation and polyploidy. 50 Oncogene-induced accumulation of DNA damage by replication stress might trigger a similar response leading to apoptosis or senescence. The mechanisms we report here might therefore have a more global role in homeostasis beyond the epidermis.
It is tempting to speculate that within the epidermis, a threshold of S-phase regulators, such as Cyclin E during the cell cycle hyperactivation that precedes terminal differentiation, might limit the number of keratinocyte divisions and thus control epidermal cell fate as a clock.
MATERIALS AND METHODS
Cell culture, plasmids and antibodies Primary keratinocytes were isolated from neonatal human foreskin and cultured in the presence of a mouse fibroblast feeder layer (inactivated by a 2 h treatment with 4 mg/ml mitomycin C), 10% serum and 1.2 mM Ca 2 þ , as described. 62 Low passages (1 --5) of keratinocytes from four different individuals were utilised. Terminal differentiation was induced by suspending disaggregated keratinocytes in culture medium supplemented with methyl cellulose (Sigma-Aldrich, Inc., St Louis, MO, USA) as described. 5, 41 For some studies keratinocytes were transferred to lowcalcium (o0.1 mM) Defined Keratinocyte-Serum-Free-Medium (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions: (i) siRNA transfections (small interfering RNA); (ii) shRNA (small hairpin RNA) lentiviral infections; and (iii) quantitation of the expression of keratins K1 and K10 by immunofluorescence or RT --PCR.
Activation of conditional MYCER 63 in primary keratinocytes was achieved by addition of 100 nM 4-hydroxytamoxifen (OHT; variant Z, Research Biochemicals International, Natick, MA, USA) to the culture medium for the lengths of time indicated.
Stem cells (SC), 'transit amplifying cells' (TAC) and terminally differentiation cells (TDC), were freshly isolated from human foreskin and sorted on basis of their adhesion capacity on collagen IV, as described. 14, 41 Primary keratinocytes were treated for 24 or 48 h with cdk inhibitors or mitosis kinase inhibitors: 50 mM of AG555 (ICN Biochemicals, Aurora, OH, USA), 30 mM of Roscovitine (Sigma-Aldrich, Inc.) and 1 mM of NG97 (kind gift of J Meijer) in DMSO; 2 mM of the Aurora B kinase inhibitor ZM447439 (Tocris Bioscience, Bristol, UK) or 100 nM of the Polo-like kinase inhibitor BI2536 (Axon MedChem BV, Netherlands) in DMSO. For DNA damage analyses cells were treated for 24 or 48 h with 0.5 mM of DOXO (SigmaAldrich, Inc.) in DMSO. Parallel control cultures were always subjected to the DMSO vehicle. Optimal concentrations were tested for each inhibitor.
For clonogenicity assays, 5000 or 10 000 of total or basal keratinocytes were plated per T6 well triplicates. Basal cells were counted on basis of their size (o18 mm). After 12 --15 days, the cultures were coloured with Rhodanile blue as described. 10 Keratinocytes were subjected to retroviral infection with pBabe constructs as described. 7 pBabe-GFP-CyclinE was constructed to express Cyclin E-GFP fusion protein in basal primary keratinocytes from pBabe-li-GFP and pBabe-CyclinE (kind gifts from Pierre Roux and Bruno Amati) as described in Supplementary Figure 8 . The studies were carried out either by analysing unselected pools 2 --5 days after infections or by stably selecting GFP or CEGFP expressing keratinocytes by 1 mg/ml puromycin.
The production of cornified envelopes was measured as described in Sun and Green. 
Flow cytometry
After removal of the mouse feeder layer, 10 6 trypsinized keratinocytes were fixed, stained for BrdU and DNA (propidium iodide), for GFP or for involucrin, and analysed by flow cytometry as described in Supplementary Data. All antibody stainings were controlled by the use of isotype negative immunoglobulins (mouse anti-cd8 or rabbit serum). In order to gate out cell aggregates, the area of the fluorescent pulse of propidium iodide (DNA content; PE-A) was plotted versus the width of the fluorescent pulse (PE-W; see Supplementary Figure 11 ).
Immunofluorescence
Keratinocytes were grown on glass coverslips and fixed and stained as described in Supplementary Data.
Whole-cell extracts and WB Cells were washed twice with phosphate-buffered saline and incubated for 30 min on ice in lysis buffer. Cell lysates were processed and subjected to WB for the molecules indicated as described in Supplementary Data.
IP and in vitro kinase assays
Cell lysates (200 mg) were incubated with specific antibodies to IP cell cycle regulators as described in Supplementary Data. The IPs were subsequently subjected to WB to determine interacting proteins or the associated kinase activity as described in Supplementary Data. siRNA transfection assays and shRNA infections Transfections with siRNA were performed on primary keratinocytes as described previously 64 using Stealth siRNA duplex for Aurora B Kinase (Invitrogen) and for a non-targeting random control siRNA. Finally, 24 h after transfection the expression of the gene was measured by RT --PCR as described below.
To inhibit endogenous regulators and to overexpress MYC, the following lentiviral plasmids were acquired: control shRNA plKO1-TRC1 from Addgene (plasmid 10879, Cambridge, MA, USA), pLKO.1 cdk1 shRNA and Cyclin E shRNA from Sigma-Aldrich, Inc. (Mission shRNA) and MycGFP from GeneCopoiea (EX-Z2845-Lv103; Rockville, MD, USA). Lentiviral production was performed by transient transfection of producer 293T cells using jetPEIt as indicated by the manufacturer (Polyplus-Transfection, Illkirch, France). After 48 h, the viral supernatant was added to primary keratinocytes cultured in DSFM serum-free medium (completed with 8 mg/ml Polybrene; Sigma-Aldrich, Inc.). The medium was changed 4 h after infection and the experiments were carried out 5 days after infection.
Reverse transcription --polymerase chain reaction Total RNA was isolated using the Trizol Reagent (Invitrogen) according to the manufacturer's instructions. In all, 2 mg of total RNA was reversetranscribed with the iScriptt cDNA synthesis kit (Bio-Rad, Hercules, CA, USA) in a 20-ml reaction for 30 min at 42 1C. The cDNAs (2 ml) were amplified by real-time PCR (Bio-Rad iQt SYBR Green supermix) using b-actin or S14 mRNA levels to normalise the data (Supplementary Table 1 ).
Cellular b-galactosidase activity Senescence was assessed by analyses of endogenous b-galactosidase activity and visualised by brightfield microscopy. 65 
